GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curocell Inc (XKRX:372320) » Definitions » Sale Of Property, Plant, Equipment

Curocell (XKRX:372320) Sale Of Property, Plant, Equipment : ₩ Mil (TTM As of Jun. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Curocell Sale Of Property, Plant, Equipment?

Curocell's sale of property, plant, equipment for the six months ended in Jun. 2023 was ₩0.00 Mil. It means Curocell gained ₩0.00 Mil from selling property, plant, and equipment.

Compared with last quarter (₩0.00 Mil in Dec. 2022 ), Curocell gained the same money from selling property, plant, and equipment in Jun. 2023 (₩0.00 Mil).


Curocell Sale Of Property, Plant, Equipment Historical Data

The historical data trend for Curocell's Sale Of Property, Plant, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curocell Sale Of Property, Plant, Equipment Chart

Curocell Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Sale Of Property, Plant, Equipment
- - - 3.50 30.91

Curocell Semi-Annual Data
Jun22 Dec22 Jun23 Dec23
Sale Of Property, Plant, Equipment - - - -

Curocell Sale Of Property, Plant, Equipment Calculation

The amount earned to sell PPE.


Curocell Sale Of Property, Plant, Equipment Related Terms

Thank you for viewing the detailed overview of Curocell's Sale Of Property, Plant, Equipment provided by GuruFocus.com. Please click on the following links to see related term pages.


Curocell (XKRX:372320) Business Description

Industry
Comparable Companies
Traded in Other Exchanges
N/A
Address
11, Gukjegwahak 16-ro, Yuseong-gu, Daejeon, KOR, 34002
Curocell Inc is engaged in medical and pharmaceutical research and development. The company is into development of CAR-T treatments that enhance the natural function of immune cells to eliminate cancer cells through genetic manipulation of human immune cells.

Curocell (XKRX:372320) Headlines

No Headlines